Results 11 to 20 of about 1,439 (152)

Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department

BMC Health Services Research, 2018
Background Limited research has assessed patient preferences for treatment disposition and antibiotic therapy of acute bacterial skin and skin structure infection (ABSSSI) in the emergency department (ED).
Safa S. Almarzoky Abuhussain, Michelle A. Burak, Kelsey N. Kohman, Gabrielle Jacknin, Serina B. Tart, Athena L. V. Hobbs, Danyel K. Adams, Michael D. Nailor, Katelyn R. Keyloun, David P. Nicolau, Joseph L. Kuti   +10 more
doaj   +5 more sources

Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia

Global & Regional Health Technology Assessment, 2020
Introduction: Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) include all complicated skin and soft tissue infections. The aim of this study was to conduct a cost-utility analysis to compare dalbavancin with standard antibiotic therapies for
Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Rosario Cultrera, Francesco Saverio Mennini   +4 more
doaj   +3 more sources

Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin [PDF]

Infection and Drug Resistance, 2018
Elda Righi, Alessia Carnelutti, Antonio Vena, Matteo Bassetti Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy Abstract: The increase in hospitalization due to acute bacterial skin and skin ...
Righi E, Carnelutti A, Vena A, Bassetti M   +3 more
doaj   +2 more sources

Current practices and challenges in the management of acute bacterial skin and skin structure infections (ABSSSI): results from an Italian multicentre survey with expert discussion. [PDF]

JAC Antimicrob Resist
Background and objectives: Acute bacterial skin and skin structure infections (ABSSSI) are common infections associated with relevant clinical and organizational burden.
Gazzola L, Augello M, Cavinato S, Briozzo A, D'Amico F, Schiano Moriello N, Segala FV, Frallonardo L, Di Gennaro F, Saracino A, Tacconi D, Gilio M, Frontuto M, Parruti G, Cattelan A, Marchetti G.   +15 more
europepmc   +2 more sources

Incidence and predictors of infections in patients with advanced non‐small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study

Scandinavian Journal of Immunology, Volume 98, Issue 3, September 2023., 2023
Abstract Immune checkpoint inhibitors (ICIs) represent the cornerstone of the current treatment of non‐small cell lung cancer (NSCLC). However, the occurrence of concomitant infections might hamper success. All consecutive patients with advanced NSCLC who started ICIs as a first‐ or second‐line therapy from January 1, 2017 to June 30, 2020 were ...
Davide Fiore Bavaro, Lucia Diella, Pamela Pizzutilo, Annamaria Catino, Fabio Signorile, Francesco Pesola, Alessandra Belati, Ilaria Marech, Vito Garrisi, Nino Lamorgese, Francesco Di Gennaro, Annalisa Saracino, Domenico Galetta   +12 more
wiley   +1 more source

Novel antimicrobial strategies to treat multi‐drug resistant Staphylococcus aureus infections

Microbial Biotechnology, Volume 16, Issue 7, Page 1456-1474, July 2023., 2023
Summary of novel strategies currently being developed to treat multi‐drug resistant Staphylococcus aureus infections. Abstract Antimicrobial resistance is a major obstacle for the treatment of infectious diseases and currently represents one of the most significant threats to global health. Staphylococcus aureus remains a formidable human pathogen with
Edward J. A. Douglas, Sri W. Wulandari, Scott D. Lovell, Maisem Laabei   +3 more
wiley   +1 more source

Multidisciplinary panel opinion on the management of bacterial skin infections

JEADV Clinical Practice, Volume 1, Issue 3, Page 165-175, September 2022., 2022
Abstract Eight hot topics regarding the diagnosis and management of bacterial skin infections were selected and reviewed by five experts from different European countries, chosen based on their expertise in microbiology, infectious diseases, and dermatology.
Emilio Bouza, Francesco Giuseppe De Rosa, Aneta Guzek, Thomas Dirschka, Giovanni Pellacani   +4 more
wiley   +1 more source

Global trends of dalbavancin: A bibliometric analysis

Journal of Clinical Pharmacy and Therapeutics, Volume 47, Issue 9, Page 1299-1311, September 2022., 2022
The bibliometric study identifies the most significant research on dalbavancin. We searched the Web of Science and found 675 documents. After ranking them by the number of times cited, we extracted T100. VOSviewer help us to identify keywords. Our study identifies the most significant research on dalbavancin, including the highest impact publications ...
Nuria Monteagudo‐Martínez, Julián Solís García del Pozo, Ichiro Ikuta, Maria Francisca Galindo, Joaquín Jordán   +4 more
wiley   +1 more source

What COVID‐19 taught us: New opportunities and pathways from telemedicine and novel antiseptics in wound healing

International Wound Journal, Volume 19, Issue 5, Page 987-995, August 2022., 2022
Abstract The COVID‐19 pandemic deeply impacted the capacity of the health systems to maintain preventive and curative services, especially for the most vulnerable populations. During the pandemic, the wound healing centres in Italy assisted a significant reduction of the frequency of their hospital admission, since only urgencies, such as severe ...
Alessandro Scalise, Marco Falcone, Giampiero Avruscio, Enrico Brocco, Eugenio Ciacco, Aurora Parodi, Rolando Tasinato, Elia Ricci   +7 more
wiley   +1 more source

Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague

British Journal of Clinical Pharmacology, Volume 88, Issue 2, Page 416-428, February 2022., 2022
Aims To develop physiologically based pharmacokinetic (PBPK) and population pharmacokinetic (PopPK) models to predict effective doses of gepotidacin in paediatrics for the treatment of pneumonic plague (Yersinia pestis). Methods A gepotidacin PBPK model was constructed using a population‐based absorption, distribution, metabolism and excretion ...
Dung Nguyen, Jafar Sadik Shaik, Guoying Tai, Courtney Tiffany, Caroline Perry, Etienne Dumont, David Gardiner, Aline Barth, Rajendra Singh, Mohammad Hossain   +9 more
wiley   +1 more source